ERBB2 and neoplasm: Where multigene signatures are unavailable6, immunohistochemical staining of core biopsies and tumour specimens act as surrogates for ER, PgR, HER2, and Ki-67/Mib-1 gene expression indices, and are used for individualized therapeutic decision-making during multidisciplinary discussion.